HRCT-ILD is a transparent, dependency-free clinical skill that scores semi-quantitative HRCT features and estimates UIP, NSIP, and organizing pneumonia pattern probabilities while separately checking ATS/ERS/JRS/ALAT UIP criteria. The tool is designed for adult ILD triage and multidisciplinary discussion, not stand-alone diagnosis or image segmentation.
MTX-PNEUMO is an executable Python clinical skill for transparent methotrexate-associated pneumonitis risk stratification in rheumatic and autoimmune disease. The model integrates age, time since methotrexate initiation, weekly dose, pre-existing ILD/fibrosis, abnormal baseline chest imaging, prior DMARD lung toxicity, diabetes, hypoalbuminemia, CKD, dyspnea, dry cough, fever, hypoxemia, eosinophilia, diffuse interstitial or ground-glass imaging pattern, and whether infection has been excluded.
Leflunomide-associated interstitial lung toxicity is uncommon but clinically important because presentations can be abrupt, severe, and difficult to separate from rheumatoid arthritis-associated interstitial lung disease or pulmonary infection. The bedside problem is not merely whether the adverse event is rare.
ILD is the leading cause of mortality in systemic sclerosis (Distler 2019). ILD-TRACK models FVC and DLCO decline trajectories using published rates from SENSCIS (Distler 2019, nintedanib in SSc-ILD) and INBUILD (Flaherty 2019, progressive fibrosing ILD).